Tradition Wealth Management LLC Has $172,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

Tradition Wealth Management LLC cut its stake in CVS Health Co. (NYSE:CVS) by 7.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,180 shares of the pharmacy operator’s stock after selling 181 shares during the period. Tradition Wealth Management LLC’s holdings in CVS Health were worth $172,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. SOA Wealth Advisors LLC. raised its holdings in shares of CVS Health by 4.9% during the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after buying an additional 133 shares in the last quarter. Apella Capital LLC raised its holdings in shares of CVS Health by 4.2% during the 4th quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock worth $272,000 after buying an additional 136 shares in the last quarter. Prairie Sky Financial Group LLC raised its holdings in shares of CVS Health by 4.1% during the 4th quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock worth $285,000 after buying an additional 141 shares in the last quarter. WealthShield Partners LLC raised its holdings in shares of CVS Health by 3.2% during the 4th quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock worth $355,000 after buying an additional 141 shares in the last quarter. Finally, Sugarloaf Wealth Management LLC raised its holdings in shares of CVS Health by 9.5% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock worth $129,000 after buying an additional 142 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at CVS Health

In other CVS Health news, Director Edward J. Ludwig purchased 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was bought at an average cost of $53.88 per share, with a total value of $53,880.00. Following the completion of the transaction, the director now owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.24% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of research reports. TD Cowen lowered CVS Health from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $99.00 to $59.00 in a research report on Tuesday, May 7th. StockNews.com lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. UBS Group lowered CVS Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $85.00 to $60.00 in a research report on Thursday, May 2nd. JPMorgan Chase & Co. reduced their price objective on CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research report on Thursday. Finally, Robert W. Baird began coverage on CVS Health in a research report on Thursday. They set a “neutral” rating and a $61.00 price objective on the stock. Eleven analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $75.05.

CVS Health Stock Up 6.4 %

CVS stock traded up $3.56 during trading on Friday, reaching $59.60. 22,366,748 shares of the stock were exchanged, compared to its average volume of 13,665,998. The firm’s 50 day moving average is $64.87 and its 200 day moving average is $71.47. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The firm has a market cap of $74.82 billion, a P/E ratio of 10.48, a price-to-earnings-growth ratio of 0.53 and a beta of 0.56.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period last year, the company posted $2.20 earnings per share. As a group, research analysts forecast that CVS Health Co. will post 7.02 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.46%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.